Skip to content
MarketScale
‹ Back to IndustriesSciences

Where Will the Money Come from in Space Sustainability?

On the Space to Grow podcast, Astroscale's Chris Blackerby and Charity Weeden interview CEO and founder Nobu Okada to explore the commercial, policy, and technological dimensions of space sustainability. The conversation addresses where funding will come from to support responsible space operations, debris removal, and long-term orbital stewardship.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Chris Blackerby · AstroscaleCharity WeedenChris BlackerbyFunding
Share

Key takeaways

01

Identifying viable commercial and governmental funding models for space sustainability initiatives.

02

International policy frameworks are critical to enabling scalable, responsible space operations.

03

Astroscale's leadership discusses the technology roadmap and business case for satellite servicing and debris removal.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

On the Space to Grow podcast, Astroscale’s Chris Blackerby and Charity Weeden bring their compelling experience and expertise to map out the technology, international policy, and scalability that will define the next generation of space exploration.

Space to Grow has an exciting episode featuring Astroscale CEO and Founder Nobu Okada. In this interview, Chris Blackerby and Charity Weeden talk to their boss and the man behind bringing awareness and industry to the space sustainability market.

Okada’s career didn’t begin in space, although space was certainly mesmerizing to him early. He traveled to the U.S. to attend Space Camp as a teen, something Weeden did, as well. The love story with space wouldn’t be a major part of his life for years. His career included work in Japan’s Ministry of Finance, as a consultant with McKinsey, and leading IT startups.

“The commercial role of space sustainability is coming, with awareness raised in the past few years” – Nobu Okada

Okada said starting Astroscale was a journey to do something different. He was looking for hot topics in space and found sustainability. He attended a global conference in April of 2013.

“No one had solutions or were taking any actions to clean up space.” So, he decided to hold that torch, founding Astroscale a week later. Since then, he’s raised over $191 million.

Raising money for any business is challenging, for space-related startups, maybe even more so because it’s not a quick return. Okada said, “Investors are simple and focused on ROI. The rules are making them feel secure, confident, and happy. We also carefully designed the terms and conditions for each series.”

Okada admits the very first series was a leap of faith for investors. “We had big passion, people, and no technology. At that point, people are investing in you.”

Since then, the company has proved the market is there. Still, it’s a slow process to transform space into a sector where commercialization is a bigger part of the picture. Now, the biggest customer for space-related solutions is government. Okada believes a turning point is coming. “We have to create the future, not wait for it. The commercial role of space sustainability is coming, with awareness raised in the past few years,” he noted.

Listen to Previous Episodes Here!

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

CB
Chris Blackerby
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

CB
Chris Blackerby

COO, Astroscale

Chris Blackerby is Chief Operating Officer at Astroscale, a company focused on satellite servicing and the long-term sustainable development of space. He has a background in space policy and international affairs, including prior roles at NASA. He co-hosts the Space to Grow podcast alongside Charity Weeden.

CW
Charity Weeden

VP, Global Space Policy

Astroscale

Charity Weeden serves as Vice President of Global Space Policy at Astroscale, where she focuses on international regulatory and policy frameworks for space sustainability. She co-hosts the Space to Grow podcast with Chris Blackerby.

NO
Nobu Okada

CEO and Founder

Astroscale

Nobu Okada is the Founder and CEO of Astroscale, which he established in 2013 with a mission to secure the safe and sustainable development of space for future generations. Under his leadership, Astroscale has become a leading commercial provider of satellite servicing and debris removal solutions.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512